Private company

BCLS II Equity Opportunities, LP

Limited partnership registered in the United States, active since 2020. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersBoston, United States²
Legal formLimited Partnership²
Kind of organizationLimited partnership²
LEI25490059C065UTQB2Q89²
StatusActive²
LEI statusIssued and current²
Registered addressC/O Maples Fiduciary Services (Delaware) Inc., 19807 Wilmington, United States²
Registered withDivision of Corporations, Department of State, 7933277²

See how the biggest companies compare on our leaderboards

Corporate structure

BCLS II Equity Opportunities, LP sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

BCLS II Equity Opportunities, LP Boston, Massachusetts, United States
- Aeglea BioTherapeutics Stake · Austin

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

Apr 13, 2020Founded BCLS II Equity Opportunities, LP is founded²

Stakes it holds

BCLS II Equity Opportunities, LP has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

Aeglea BioTherapeuticsSC 13G/A Feb 14, 2022 to Feb 13, 2024³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBCLS II Equity Opportunities, LP filings on SEC EDGAR
2
GLEIFBCLS II Equity Opportunities, LP LEI record (25490059C065UTQB2Q89)
3
SEC EDGARBCLS II Equity Opportunities, LP SC 13G/A on Aeglea BioTherapeutics